Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.45
-0.17 (-3.02%)
At close: Oct 2, 2026, 4:00 PM EDT
5.44
-0.01 (-0.18%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.95 billion as of October 2, 2026. Its market cap has decreased by -24.12% in one year.
Market Cap
1.95B
Enterprise Value
3.25B
1-Year Change
-24.12%
Ranking
Category
Stock Price
$5.45
ChartMarket Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.95B, an increase of 538.42%. That is a compound annual growth rate of 36.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.95B | 21.14% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.47B |
| Supernus Pharmaceuticals | 2.46B |
| Bausch Health Companies | 2.17B |
| Prestige Consumer Healthcare | 2.14B |
| BioCryst Pharmaceuticals | 2.09B |
| Trulieve Cannabis | 2.06B |
| Perrigo Company | 1.98B |
| Xeris Biopharma Holdings | 1.66B |